Xenopus laevis provides a number of advantages to studies on cardiovascular development. The embryos are fairly large, are easy to obtain, and can develop at ambient temperature in simple buffer solutions. Although classic descriptions of heart development exist, the ability to use whole-mount immunohistochemical methods and confocal microscopy may enhance the ability to understand both normal and experimentally perturbed cardiovascular development. We have started to examine the early stages of cardiac development in Xenopus, seeking to identify antibodies and fixatives that allow easy examination of the developing heart. We have used monoclonal antibodies (mAbs) raised against bovine cardiac troponin T and chicken tropomyosin to visualize cardiac muscle, a goat antibody recognizing bovine type VI collagen to stain the lining of vessels, and the JB3 mAb raised against chicken fibrillin, which allows the visualization of a variety of cardiovascular tissues during early development. Results from embryonic stages 24 -46 are presented.
INTRODUCTION
Although some aspects of development are unique to a particular species, many features of developmental specification and organogenesis are shared. The frog Xenopus laevis has particular advantages for the study of organogenesis in general and cardiovascular development in particular. These aquatic frogs are easily maintained in the laboratory and can be induced to lay eggs year round by hormonal stimulation. The fertilization and embryonic development is external, with the lineage of many tissues well established. In addition, the size of the egg and early embryo allows straightforward micromanipulation including microinjection and microdissection as a means to experimentally alter early development. Without providing an exhaustive listing of studies that impact on cardiovascular development, one can point to mRNA injection studies that have helped to elucidate the function of the genes Nkx2.3 and 2.5 (Cleaver et al., 1996; Evans et al., 1995; Grow and Krieg, 1998) , PitX2 (Ryan et al., 1998) , VEGF (Cleaver et al., 1997) , Tbx5 (Horb and Thomsen, 1999) , and Vg1 (Hyatt and Yost, 1998) . The analysis of cardiac-specific promoters, like cardiac actin (Taylor et al., 1989) , and expression studies using dominant negative proteins (Fu et al., 1998; Grow and Krieg, 1998) have also been carried out in developing tadpoles.
Although the simple visual inspection of the heart can provide information on size or whether it looped to the right or left, the assessment of internal changes in the cardiac valves or septa requires a more invasive analysis. The interpretation of changes due to experimental manipulation requires a clear understanding of what a normal heart looks like at specific stages of development and some idea of when different structures normally form. Although sectioned material can reveal perturbations in the developmental pattern, this approach is tedious and requires an intimate familiarity with the normal pattern as seen in a two-dimensional plane.
The need for generally accepted baseline information led Nieuwkoop and Faber and more than 20 collaborating scientists to compile the Normal Table of Xenopus laevis (Daudin) . These authors provided a narrative of overall development and drawings of whole embryos at each developmental stage from fertilization until about 2 months later when the embryo has progressed into a small frog (Nieuwkoop and Faber, 1967) . A complementary work by Hausen and Riebesell, The Early Development of Xenopus laevis, provides a very useful histological account of early development but stops at the stage when the actual morphological differentiation of the heart starts (Hausen and Riebesell, 1991) . Here we use whole-mount immunohistochemistry and confocal microscopy to visualize the developing frog heart. We have concentrated on stages in which the first expression of cardiac muscle can be detected through the development of cardiac valves and septa about 5 days later. Our aim was to identify fixation procedures that, coupled with readily available antibodies, would allow a dynamic view of the normal formation of the early heart and thus provide a "standard template" for the comparison of abnormal hearts.
MATERIALS AND METHODS
Animals. X. laevis were purchased from Xenopus I (Ann Arbor, MI). Females were induced to lay eggs by injection with 200 units of pregnant mare serum gonadotropin (Sigma Chemical, St. Louis, MO) at least 3 days prior to injection with human chorionic gonadotropin (500 -1000 units; Sigma Chemical). Eggs were collected in egg-laying buffer (100 mM NaCl, 2 mM KCl, 0.2 mM MgSO 4 , 0.4 mM CaCl 2 , 5 mM Tris (pH 7.6)) to prevent the swelling of the jelly coat. Testes were removed from male frogs that had been euthanized with 1 ml of a 10 mg/ml solution of tricane (Sigma Chemical). A small piece of testes was crushed in 0.1 MMR (1ϫ MMR is 100 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 5 mM Hepes (pH 7.4)) and added to the eggs after nearly all the egg-laying buffer was removed from the eggs. The egg/sperm mix was flooded with water and the embryos were allowed to develop at room temperature. Embryonic stages were identified by the criteria described in Nieuwkoop and Faber (1967) .
Fixation and immunohistochemistry. Tadpoles were fixed in Dent's fixative (80% methanol, 20% dimethyl sulfoxide (DMSO)) and stored at Ϫ20°C until processed. Except where noted, subsequent treatments and rinses were carried out on samples in 24-well plates on an orbital shaker. In cases in which embryos younger than stage 40 were heavily pigmented, samples were bleached prior to addition of antibodies. Bleaching was carried out using 5% hydrogen peroxide (in Dent's fixative) in clear glass vials rotating in bright light for 4 -5 h, then the sample was returned to Dent's and either stored at Ϫ20°C or further processed. Prior to immunolabeling, the ventral dermal layer overlying the hearts of stage 44 and 46 tadpoles was manually removed to help antibody penetration and ensure optimal imaging of the hearts.
Embryos were rehydrated to PBS in a methanol-PBS series which included 1% DMSO at each step. Embryos were then treated with bovine testicular hyaluronidase (1 mg/ml in 50 mM acetate buffer) 30 -45 min at room temperature, rinsed in PBS-TD (PBS, 1% Tween 20, 1% DMSO, 0.02% NaN 3 ), and blocked for 4 h at room temperature or overnight at 4°C in block solution (PBS-TD containing 0.1 M glycine, 2% powdered milk, and 5% serum from the host species of the secondary Ab or 1% BSA). Primary antibodies were diluted with block solution as follows: goat anti-bovine type VI collagen (Southern Biotechnology Associates)-1:50, mouse anti-bovine cardiac troponin T (CT3; Developmental Studies Hybridoma Bank (DSHB), University of Iowa)-1:10, mouse antichicken tropomyosin (CH1; DSHB)-1:50, and mouse anti-chicken fibrillin (JB3; gift from Dr. Charlie Little, Medical University of South Carolina)-1:50. Incubation with primary antibody was carried out overnight at 4°C. Samples were then rinsed six to eight times over 8 -10 h with PBS-TD. Secondary antibodies were used as follows: anti-goat conjugated to Alexa 488, anti-mouse conjugated to Alexa 568 (both from Molecular Probes), anti-goat conjugated to Cy5, and anti-mouse conjugated to Cy5 (both from Jackson ImmunoResearch). All were diluted 1:200 in blocking solution and allowed to incubate with the sample overnight at 4°C. Samples were rinsed as described for primary antibody treatment and subsequently dehydrated in an ethanol series.
Double labeling with anti-fibrillin (JB3) and either anti-troponin (CT3) or anti-tropomyosin (CH1) required a more elaborate procedure as all three antibodies were raised in mouse. Using the same solutions and dilutions for rinsing, blocking, and antibody incubation as described above, the double labeling was carried out according to procedures described by Jackson ImmunoResearch. Samples were incubated with CT3 or CH1 (we found that using the antibodies made against muscle first was much more effective than starting with JB3) and then rinsed six to eight times over 8 -10 h with PBS-TD. Samples were then incubated overnight with rabbit anti-mouse conjugated to Cy5 (we found that using the Cy5 conjugate to detect the muscle worked better for early embryos than using the Alexa 568 conjugate). Samples were rinsed six to eight times over 8 -10 h with PBS-TD and then incubated with 5% heat-inactivated normal mouse serum (heat inactivated at 60°C for 30 min) for 4 h at room temperature followed by rinsing 3ϫ over 3 h. Samples were then incubated in unconjugated rabbit antimouse Fab (Jackson ImmunoResearch; 0.025 mg/ml) diluted in blocking solution, overnight at 4°C, and subsequently rinsed six to eight times over 8 -10 h with PBS-TD. Samples were then incubated with JB3 overnight and rinsed six to eight times over 8 -10 h with PBS-TD. Samples were then incubated overnight with rabbit anti-mouse conjugated to Alexa 568. Samples were rinsed as described for primary antibody treatment and subsequently dehydrated in an ethanol series.
A Western blot of homogenized, sonicated stage 35 embryonic tissue was performed. Twenty micrograms of pellet or supernatant protein (after a 10,000-rpm, 10-min centrifugation using a Hermle microcentrifuge) was loaded under reducing conditions onto a precast 4 -15% polyacrylamide minigel (Bio-Rad). Proteins were electrophoresed and then transferred onto Protran (Schleicher & Schuell) or Immobilon-P (Millipore). Membranes were blocked 1 h in TBS-T (Tris-buffered saline containing 0.5% Tween 20) containing 5% dry milk. The membranes were then incubated in primary antibodies diluted in block as follows: CH1-1:500, CT3-1:100, JB3-1:250. Blots were then rinsed in TBS-T containing 1% milk and then incubated in secondary antibody, peroxidase-conjugated donkey anti-mouse IgG (Jackson ImmunoResearch) 1:10,000 in block. Membranes were then rinsed in TBS-T and ECL (Pierce) was carried out. Only the CH1 antibody showed strong reactivity to a protein of approximately 38 kDa. Thus, immunohistochemical reactivity cannot be directly correlated with the effective use of these antibodies for Western blot analysis of Xenopus proteins.
Embryos were mounted for viewing in " mounting wells" constructed by filling the depressions of concave slides with Sylgard 184 silicone elastomer (Dow Corning) working solution and allowing polymerization at 55°C overnight. Wells to accommodate the embryos were carved out of the elastomer with a scalpel. Prior to mounting of specimens younger than stage 35, the caudal half of the embryo was removed (we empirically found better imaging when this dissection was performed). Embryos were positioned in the mounting wells and excess EtOH was removed. The specimens were held down with forceps as the clearing agent, BABB (benzyl alcohol:benzyl benzoate, 1:2, adjusted to pH 7.0), was added since the embryos became buoyant in the dense BABB and were difficult to reposition after clearing. The pH of the BABB used was routinely brought near neutral by stirring it in the presence of NaOH pellets. Embryos were covered with a coverslip and viewed on a Nikon Optiphot/Bio-Rad MRC-1024 confocal microscope equipped with a krypton/argon laser. Images were initially saved at a resolution of 1024 ϫ 1024 pixels/in. In some cases the resolution was reduced to accommodate memory capacity of computers and/or printers. Confocal Assistant 4.02 and Adobe PhotoShop 5.0 were used for image processing.
RESULTS

Antibodies Recognizing Structural Proteins of Cardiac Muscle Provide an Overview of Myocardial Development.
In Nieuwkoop and Faber (1967) the initial development of the heart is described as follows, "two presumptive heart anlagen, located in the anterior, latero-ventral mesoderm at stage 15, begin to fuse at stage 16. . .a single median presumptive heart anlage is not established before stage 19. . .becomes more sharply delimited during the following stages the actual differentiation of the heart anlage only starts at about stage 27" (about 31 h after fertilization of the egg). We assumed that the expression of muscle proteins would provide a recognizable hallmark of early heart differentiation. In addition, the conservation of muscle proteins among species made it likely that antibodies raised against chicken tropomyosin (CH1) or bovine cardiac troponin T (CT3) would recognize the same proteins in frogs.
When we examined stage 27 embryos using an Ab directed against tropomyosin (Fig. 1) , populations of cells from both sides of the ventral midline were easily recognized, forming a delta-shaped region most narrow in the anterior region of the embryo. By stage 31 (about 38 h postfertilization; Fig. 1 ), the posterior region of myocardium bulges ventrally and the triangular shape of the field is less broad at its posterior base. By stage 33/34 (about 42 h after fertilization) the heart has started to twist, resulting in the S-shaped structure seen in stage 35 (50 h postfertilization). By stage 41 (76 h postfertilization) the myocardial staining of both the ventricle and the truncus show that these structures have thickened. By stage 46 (106 h postfertilization) enough time has passed for the atria to have formed. The ventral view of the heart allowed the easy observation of both ventricle and outflow tract. The micrographs of the hearts in Fig. 1 , along with the embryos as depicted by Nieuwkoop and Faber (1967) , provide a view of the progressive formation of heart from the perspective of the myocardium.
Nonmyocardial Cell Participation in Heart Development Can Be Visualized Using JB3 Antibody
We have not yet identified an antibody that can be used in all developmental stages to identify the endothelium in the heart. However, the Ab JB3 (anti-fibrillin) allows a view of the heart field that differs from that seen with the antibodies that stain the myocardium. Fibrillin is one of the proteins that has been identified in the extracellular matrix, especially in the microfibrils that are associated with elastic tissues and basement membranes (Sakai et al., 1986) . Several studies have shown that fibrillin can be seen along the anterior-posterior axis of chick embryos as the notochord forms. Fibrillin is also found in association with a subpopulation of cardiac endothelial cells and the mesenchyme and mesenchymal derivatives that form the valves and septa of the heart (Gallagher et al., 1993; Hurle et al., 1994; Wunsch et al., 1994) . With these findings in mind we tested frog embryos for reactivity with JB3. It is important to note here that we have not established that Xenopus fibrillin is the protein recognized, although that is the simplest interpretation of the data. In the stage 27 heart ( Fig. 2A) JB3 outlines cells in a much narrower region than what was seen using the muscle markers. In the view presented ( Fig. 2A) , the staining seen is consistent with the description of endocardial tube formation in Nieuwkoop and Faber (1967) , which states "At stage 28 the endocardial tube appears as a condensation of cell material with the beginning of a central dilatation." We interpret the staining in Fig. 2A as the secretion of JB3-reactive antigen into the mesocardial space between the muscle and the endocardial precursors. At this stage (in contrast to data shown for stage 28 in Fig. 3 ) the endocardial lumen has not yet formed. Later, by stage 35 (Fig. 2B) , the staining pattern outlines the endocardial tube, allowing the identification of the atrioventricular cushions and emphasizing the bending of the heart at this stage.
Double Staining of Whole-Mount Embryos Provides a More Complete Picture of Cardiac Development
Embryos were simultaneously stained with JB3 and antibodies that recognize muscle to better understand the onset of differentiation, the position of the endocardial tube within the developing myocardium, and the formation of the valves and septa. In Figs. 3 and 4 selected optical sections of stages 24, 26, 28, 31, 35, 41 , and 44 are presented
FIG. 1. Cardiac muscle development in Xenopus.
Confocal images of the heart regions of six stages of embryos (27-46) are presented (ventral views), each adjacent to a diagrammatic representation of an embryo (Nieuwkoop and Faber, 1967) at the corresponding stage. Prior to microscopy, stage 27-33 embryos were immunolabeled with anti-tropomyosin (CH1) and stages 35-46 with anti-cardiac troponin T (CT3). The secondary antibody used for all stages was conjugated to Cy5. Each confocal image represents a digitally colored compilation of 30 -53 optical sections taken (in gray scale) 5-7 m apart. All confocal images were taken at the same magnification and are presented with the anterior of the embryo at the top. Scale bar, 100 m.
with the location of JB3-reactive material shown in green and tissue reacting with CT3 or CH1 in red. Identification of structures in the micrographs was based upon descriptions from Hausen and Riebesell (1991) for stages 24, 26, and 28 and on Nieuwkoop and Faber (1967) for all stages. In stage 24 (Fig. 3A) , a parasagittal section of an embryo is shown. At this stage the heart anlage is present, but not strongly reactive with either antibody. However, the head mesenchyme and notochord are reactive to JB3 and there is strong somitic staining using CH1 (anti-tropomyosin). The JB3 staining at this stage is reminiscent of that previously reported in quail in which prominent staining was present around (Rongish et al., 1998 ) the somites demarcating the notochord. We detected staining in the presumptive heart region by stage 26 (left lateral ventral view, Fig. 3B ), slightly earlier than expected. If examined from a ventral view, the stained region appears much less triangular than in stage 27 (Fig. 1) and less intense, signifying lower levels of antigen.
Both antigens are most evident in cells nearest to the midline with JB3 confined to a narrower region.
By stage 28 (Figs. 3C and 3D ), myocardial staining is easily seen with JB3-reactive material enclosed within the field of myocardial tissue. At this point the myocardial tissue does not join dorsally to form a tube although the development toward a tubular shape is apparent. In Fig. 3D , JB3 staining is concentrated in two regions that run along the anterior to posterior axis of the heart next to the myocardial staining, suggesting that the lumen of the endocardial tube has formed. By stage 31 (Figs. 3E-3I ) most of the myocardial region of the heart is still a trough rather than a tube as the dorsal portion of the myocardial wall is still unfused. The first hint of myocardial tube closure comes at the posterior end of the heart. The heart tube is slightly bent, laterally to the right side of the embryo. In micrographs not presented one can see that the myocardial wall completes closure by stage 33. The S-shaped heart tube By stage 46 (Figs. 5A-5F ) the embryonic heart has most of the structures found in adult heart (U. Tajchman, unpublished; Deuchar, 1975; Nieuwkoop and Faber, 1967) . Starting on the ventral side of the embryo, optical sectioning through the double-stained heart highlights the muscular ventricle and the presence of a spiral valve in the truncus arteriosus (Figs. 5A and 5B). Progressing through the heart the atrioventricular valve (Fig. 5C) , the two atria, and the atrial septum sequentially come into view (Figs. 5D-5F ).
The vascular system surrounding the heart is easily viewed by costaining using anti-troponin and anti-type VI collagen (Fig. 6) . The truncus splits into paired aortic arches that further branch three times to form the carotid, systemic, and pulmocutaneous arches. In this ventral view the right set of arches is partially obscured by the truncus arteriosus.
DISCUSSION
Since Nieuwkoop and Faber and their collaborators painstakingly described the embryogenesis of Xenopus in 1956 a FIG. 5. Ventral-to-dorsal progression through a stage 46 Xenopus heart. Images were digitally created from a series of 48 optical sections (taken 5 m apart) through a double-labeled stage 46 Xenopus heart (red, CT3; green, JB3). Image A represents the most ventral 8 images of this series, digitally merged; image B, the next 8, etc. The relative positioning of heart structures to one another, as well as an individual structure's order of emergence within the series, can be established: the truncus arteriosus and ventricle are always most ventral (A). Progressing dorsally, the spiral valve (B) appears within the truncus. Next, the single atrioventricular valve (C) is seen overlying the atrial septum (D and E). Midway through the series (C and D), the first views of the atria, as well as the aortic branches, are viewed. Both atria and the sinus venosus are seen more dorsally (D and E). Finally, the back wall of the atria is seen, positioned most dorsal (F). Scale bar, 100 m.
variety of technological advances have been made with respect to the ability to visualize embryonic development. The combined efforts of a large number of investigators have refined the use of immunohistology and whole-mount fixation techniques (Harland, 1991; Klymkowsky and Hanken, 1991) . Advances in computational capacity, together with confocal microscopy, provide a means to capture digital information. These data can be viewed as single thin sections or stacked into a three-dimensional view of the developing frog heart.
The identification of gene products that are implicated in proper cardiovascular development has also accelerated (Harvey et al., 1997) . As the functions of these genes are investigated, it is critical that the endpoint of the analysis becomes more than the appearance or disappearance of bands on an agarose gel. The consequence on normal structure must also be examined. Thus, clear and reproducible images of structure need to be accessible for comparative interpretation of data.
With this in mind we have sought to optimize techniques that provide a straightforward look at the development of the frog heart. For the antibodies used in this paper both paraformaldehyde-based (Harland, 1991) and DMSO/ methanol (Klymkowsky and Hanken, 1991) tissue fixatives were tried. Far better results were found using DMSO/ methanol. While other antibodies may give optimal results with other fixatives we observed that paraformaldehydefixed embryos tended to have higher nonspecific background fluorescence. Many chromofluors are pH sensitive and for the studies described here we noted that the clearing agent BABB has a relatively acidic pH. We routinely brought the pH to near neutral by stirring the BABB in the presence of NaOH pellets until the solution was about pH 7. In some stages, to assist penetration of reagents and also simplify confocal analysis of the heart, we physically removed ventral dermis or the dorsal half of the embryo.
For the examination of myocardial development, we used two antibodies, CH1 and CT3, available through the Developmental Studies Hybridoma Bank. Although neither was originally raised against frog protein, they provide consistent and strong staining of muscle tissues in the embryos. Using these antibodies, myocardial field establishment, tube closure, and development of the outflow tract, atria, and ventricle are all readily imaged. In addition, we were able to detect differentiation, indicated by the expression of muscle proteins, slightly earlier than was possible by visual inspection of the embryo (stage 27 was the onset of differentiation reported in Nieuwkoop and Faber, 1967) . We found that in stage 26 the region of staining was oval, centered, and concentrated on the ventral midline. This contrasts with the triangular region of staining seen by stage 27 (Fig. 1 ) and with in situ detection shown by others of several muscle mRNAs. In situ studies indicate that two distinct lateral regions of gene expression bracket the ventral midline (for in situ data see Cleaver et al., 1996; Drysdale et al., 1994) . We note that heart muscle mRNA in these distinct lateral fields can be detected in stages prior to our ability to see protein (P. Krieg, personal communication). Future studies with other antibodies may be informative concerning the progression from muscle gene activation to production of muscle protein.
By using the anti-fibrillin antibody JB3 the formation of the endocardium can be viewed via its secretion of the JB3 epitope into the extracellular matrix that lies between the myocardium and the endocardium. Specific epitope detection results in slightly lower apparent resolution when viewed in contrast to what was seen with CH1 or CT3, which would be expected for a secreted molecule. However, as early as we could detect myocardial staining we also detected JB3 epitope staining. JB3 staining began as a mass in the heart-forming region and by stage 28 was displayed in a manner consistent with its secretion between the endocardium and the myocardium and not into the lumen of the endocardial tube. Fortuitously, we found that when we used a high concentration of the JB3 Ab, nonspecific background staining increased the ability to view many heart structures, including myocardial and endocardial tissues and the valves and septa of the heart.
Being able to recognize normal and altered cardiac development in Xenopus will allow both the similarities and the differences between Xenopus and other organisms to be used to best advantage. There are clear differences in the details of cardiac development when Xenopus is compared to mammals. For instance, although paired lateral primordia are present in both systems, in Xenopus these primordia meet at the anterior ventral midline prior to the formation of either endocardial or myocardial tubes. Thus, the fusion events that form the hearts of amniotes are not identical to that seen in Xenopus, although the outcome is very similar. Ultimately, Xenopus hearts have only three chambers with a single ventricle while mammals have four chambers. In addition the truncus arteriosus in the frog does not divide into the aorta and pulmonary artery but separates blood flow by a spiral valve. The spiral valve (Nieuwkoop and Faber, 1967 ) is remarkably like the aorticopulmonary septum that can be seen in a 6-week human heart (Sadler, 1990) and its persistence throughout development may serve as a model for defects involving persistent truncus arteriosus.
Many features that were seen by confocal imaging of X. laevis hearts have a direct correlate in mammalian heart development. Characteristic asymmetries are common to Xenopus and mammalian hearts, including the leftward bend of the outflow tract and the division of the early atrium into right and left side (with the right side being larger) by the formation of an atrial septum. The control and restriction of blood flow between the atria and the ventricle is accomplished by the atrioventricular valve. In both frog and mammal the musculature of the ventricle is thicker than that found in the atrium and includes the development of trabeculae. The similarity continues at the molecular level with the strong conservation of both regulatory factors and the expression of structural proteins of cardiovascular development.
We believe that both the similarities and the differences should prove useful in studies that aim at understanding heart formation and congenital heart defects. The ability to view the overall changes that accompany cardiogenesis using confocal microscopy enhances the ability to understand the function of gene products involved in proper cardiovascular development.
